Home› Stocks› JNJ
Not investment advice. AI-generated analysis for educational purposes only. All trading involves risk of loss. Past performance does not guarantee future results. Full disclaimer

JNJ

BUY

Health Care · S&P 500

Last updated: April 12, 2026 at 03:42 UTC

TRADEWISE AI SCORE

69

out of 100 — 6-factor composite

6-Factor Analysis

Based on Jegadeesh & Titman (1993) momentum and Barroso & Santa-Clara (2015) volatility targeting.

FactorValueStrengthDetail
Composite Momentum +25.5%
Multi-timeframe weighted (1/3/6/12mo)
Relative Strength vs SPY +17.4%
3-month outperformance vs S&P 500
20-Day Momentum -1.9%
Short-term price momentum
RSI-14 56.9
Relative Strength Index
Volatility 14.4%
20-day annualised: 14.4%

AI Debate Summary

4 AI agents (Research, Risk, Macro, Devil's Advocate) debated JNJ.

AI Debate from April 09, 2026 — data may be outdated. Get fresh analysis
ATLAS HOLD 48.0%

# ATLAS RESEARCH ANALYSIS: JNJ (Johnson & Johnson) --- ## ASSESSMENT: NEUTRAL / HOLD Johnson & Johnson remains a **world-class healthcare franchise with elite fundamentals**, but the current setup

Read full analysis →

SENTINEL HOLD 58.0%

# SENTINEL RISK ASSESSMENT: JNJ (2026-04-09) --- ## ASSESSMENT: NEUTRAL (Lean Bearish on Risk/Reward Geometry) JNJ is a **world-class fortress**: 60+ years of uninterrupted dividend growth, fortres

Read full analysis →

HORIZON AVOID 55.0%

# HORIZON MACRO ASSESSMENT: JNJ (Johnson & Johnson) **DATE: 2026-04-09 | REGIME: UPTREND (Score: 18.6) | EARNINGS: 2026-04-14 (5 days)** --- ## 1. ASSESSMENT: NEUTRAL-TO-BULLISH The macro environme

Read full analysis →

CONSENSUS HOLD — 54% agreement

Full debate reasoning available on Pro tier.

Market Regime Context

CURRENT REGIME CHOPPY (Day 1)

TradeWise monitors 5 market states (CALM → CRISIS) using VIX, breadth, and tail risk signals. In CHOPPY regime, the system adjusts position limits, trailing stops, and cash reserves automatically. Learn more about regime detection.

Get real-time AI alerts for JNJ

4 AI agents debate every trade. 6-factor scoring. Regime-adaptive risk management. 14-day free trial, no credit card.

Start Free Trial →

Health Care Sector Peers

LLYUNHABBVMRKTMOABTDHRPFEAMGNISRG

View all Health Care stocks →

Compare

JNJ vs LLYJNJ vs UNHJNJ vs ABBVJNJ vs MRKJNJ vs TMO

Frequently Asked Questions

Is JNJ a buy right now?

Based on TradeWise's 6-factor AI model, JNJ currently scores 69/100, indicating a BUY signal. This combines momentum, volume, trend structure, volatility, sector relative strength, and drawdown analysis. The current market regime is CHOPPY. Updated April 12, 2026 at 03:42 UTC.

What is the TradeWise AI score for JNJ?

JNJ has a TradeWise AI score of 69/100. Scores above 80 indicate STRONG BUY, 65-80 BUY, 45-65 HOLD, 30-45 WEAK, below 30 AVOID. Scores are updated daily based on the V56 momentum engine scanning all S&P 500 stocks.

How does JNJ compare to LLY?

Compare JNJ against sector peers using our head-to-head AI comparison tool. Each comparison shows 6-factor score breakdown, AI debate excerpts, and regime-adjusted analysis. See comparison →

Disclaimer: TradeWise provides AI-generated analysis for educational purposes only. This is not financial advice. Past performance does not guarantee future results. All investing involves risk of loss. Backtested results are hypothetical. Consult a qualified financial adviser before making investment decisions. Scores generated by the V56 momentum engine based on Jegadeesh & Titman (1993) momentum research and Barroso & Santa-Clara (2015) volatility targeting.